One of the biggest misconceptions in biotechnology is that every company intends to become a fully integrated pharmaceutical organization. Most do not. From the moment a company receives its first institutional investment, leadership begins making decisions that shape the company's future. Those choices influence clinical development, manufacturing, hiring, capital allocation, commercial planning, and ultimately how the company will create value. While every biotechnology company is unique, most successful organizations pursue…
Full article
Full article available by request only.
Contact PharmaKonsult to request the complete opinion paper.